Ducharme is a contributor to TIME. Rick Doblin When Rick Doblin, 70, was in his 20s, he had a dream that changed not only his life, but also—in a roundabout way—the trajectory of U.S. public health.
MIAMI, March 29, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or the "Company") (OTC: BWVI), a bioscience company dedicated to developing cutting-edge technologies for ...
Psycheceutical Chief Visionary Officer Zappy Zapolin and CEO Chad Harman with MAPS Founder Rick Doblin MIAMI, March 29, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical" or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results